Lv5
930 积分 2026-04-09 加入
Secukinumab in moderate to severe hidradenitis suppurativa: Primary endpoint analysis from the SUNSHINE and SUNRISE Phase 3 trials
7天前
已完结
Two phase III trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper
7天前
已完结
Two phase III trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper
21天前
已完结
Secukinumab in moderate to severe hidradenitis suppurativa: Primary endpoint analysis from the SUNSHINE and SUNRISE Phase 3 trials
21天前
已完结
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa-A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial
1个月前
已完结
The Therapeutic Effect and Potential Pharmacological Mechanisms of Ding-Zhi-Xiao-Wan on Depression were Investigated by Meta-analysis, Network Pharmacology and Molecular Docking
3个月前
已完结
皖公网安备34019202002308
